241 related articles for article (PubMed ID: 25542236)
1. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma.
Ruiz-Morales JM; Dorantes-Heredia R; Arrieta O; Chávez-Tapia NC; Motola-Kuba D
Tumour Biol; 2015 May; 36(5):3601-10. PubMed ID: 25542236
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G
Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1.
Mir SU; Jin L; Craven RJ
J Biol Chem; 2012 Apr; 287(18):14494-501. PubMed ID: 22418433
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9.
Gupta K; Shukla M; Cowland JB; Malemud CJ; Haqqi TM
Arthritis Rheum; 2007 Oct; 56(10):3326-35. PubMed ID: 17907186
[TBL] [Abstract][Full Text] [Related]
5. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin.
Serra R; Buffone G; Falcone D; Molinari V; Scaramuzzino M; Gallelli L; de Franciscis S
Wound Repair Regen; 2013; 21(3):395-401. PubMed ID: 23531093
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer.
Bauer M; Eickhoff JC; Gould MN; Mundhenke C; Maass N; Friedl A
Breast Cancer Res Treat; 2008 Apr; 108(3):389-97. PubMed ID: 17554627
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of Neutrophil gelatinase-associated lipocalin(NGAL) expression in primary rectal cancer.
Zhang XF; Zhang Y; Zhang XH; Zhou SM; Yang GG; Wang OC; Guo GL; Yang GY; Hu XQ
BMC Cancer; 2009 May; 9():134. PubMed ID: 19419554
[TBL] [Abstract][Full Text] [Related]
8. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.
Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ
Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of neutrophil gelatinase-associated lipocalin in head and neck squamous cell carcinoma correlated with tumorigenesis, not with metastasis.
Wang L; Chen C; Li F; Hua Q; Chen S; Xiao B; Dai M; Li M; Zheng A; Yu D; Hu Z; Tao Z
Int J Clin Exp Pathol; 2015; 8(8):8857-68. PubMed ID: 26464627
[TBL] [Abstract][Full Text] [Related]
10. Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Activity in Human Glioma Samples Predicts Tumor Presence and Clinical Prognosis.
Liu MF; Hu YY; Jin T; Xu K; Wang SH; Du GZ; Wu BL; Li LY; Xu LY; Li EM; Xu HX
Dis Markers; 2015; 2015():138974. PubMed ID: 26663949
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.
Wang M; Zhang Q; Zhao X; Dong G; Li C
Crit Care; 2014 Nov; 18(6):634. PubMed ID: 25407832
[TBL] [Abstract][Full Text] [Related]
12. [The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].
Perrin C; Patard JJ; Jouan F; Collet N; Théoleyre S; Edeline J; Zerrouki S; Laguerre B; Bellaud-Roturaud MA; Rioux-Leclercq N; Vigneau C
Prog Urol; 2011 Nov; 21(12):851-8. PubMed ID: 22035911
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
Provatopoulou X; Gounaris A; Kalogera E; Zagouri F; Flessas I; Goussetis E; Nonni A; Papassotiriou I; Zografos G
BMC Cancer; 2009 Nov; 9():390. PubMed ID: 19889214
[TBL] [Abstract][Full Text] [Related]
14. NGAL controls the metastatic potential of anaplastic thyroid carcinoma cells.
Volpe V; Raia Z; Sanguigno L; Somma D; Mastrovito P; Moscato F; Mellone S; Leonardi A; Pacifico F
J Clin Endocrinol Metab; 2013 Jan; 98(1):228-35. PubMed ID: 23150684
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Inhibiting NGAL Gene Expression on A549 Lung Cancer Cell Migration and Invasion].
Tang J; Li J; Li S; Li J; Yu C; Wei C
Zhongguo Fei Ai Za Zhi; 2015 Apr; 18(4):187-92. PubMed ID: 25936881
[TBL] [Abstract][Full Text] [Related]
16. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
Zhang Y; Fan Y; Mei Z
Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
[TBL] [Abstract][Full Text] [Related]
17. Urinary ADAM12 and MMP-9/NGAL complex detect the presence of gastric cancer.
Shimura T; Dagher A; Sachdev M; Ebi M; Yamada T; Yamada T; Joh T; Moses MA
Cancer Prev Res (Phila); 2015 Mar; 8(3):240-8. PubMed ID: 25591790
[TBL] [Abstract][Full Text] [Related]
18. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.
Moniaux N; Chakraborty S; Yalniz M; Gonzalez J; Shostrom VK; Standop J; Lele SM; Ouellette M; Pour PM; Sasson AR; Brand RE; Hollingsworth MA; Jain M; Batra SK
Br J Cancer; 2008 May; 98(9):1540-7. PubMed ID: 18392050
[TBL] [Abstract][Full Text] [Related]
19. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction.
Hemdahl AL; Gabrielsen A; Zhu C; Eriksson P; Hedin U; Kastrup J; Thorén P; Hansson GK
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):136-42. PubMed ID: 16254208
[TBL] [Abstract][Full Text] [Related]
20. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
Fernández CA; Yan L; Louis G; Yang J; Kutok JL; Moses MA
Clin Cancer Res; 2005 Aug; 11(15):5390-5. PubMed ID: 16061852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
